March 23, 2024
2 min watch
Save
VIDEO: Low-dose atropine may play important role in fight against myopia
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
WAILEA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2024, Benjamin H. Ticho, MD, discusses the growing prevalence of myopia worldwide and the role that low-dose atropine may play in treating it.
Conditions such as glaucoma, cataracts, retinal tears, retinal detachments and retinal myopic degeneration, which are all pathologic complications of myopia, will be some of “the biggest causes of worldwide blindness in the coming decades. So, we’re hoping that low-dose atropine provides some preventative treatment for these patients,” Ticho said.
Published by:
Sources/Disclosures
Collapse
Source:
Ticho BH. 2024 update: Low-dose atropine for myopia. Presented at: Hawaiian Eye 2024; Jan. 13-19, 2024; Wailea, Hawaii.
Disclosures:
Ticho reports being an investigator for the PEDIG and Sydnexis studies.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.